RNAi specificity: how big of an issue is it?

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.1, 2005-01, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Adverse Drug Events in Children: How Big is the Problem?

Drug Metabolism Letters, Vol. 9, Iss. 2, 2015-08 ,pp. : 109-110

Bentham Science Publishers

Access to resources Recommend Favorite

Variability in susceptibility - how big, how often, for what responses to what agents?

By Hattis D.

Environmental Toxicology and Pharmacology, Vol. 2, Iss. 2, 1996-10 ,pp. : 135-145

Elsevier

Access to resources Recommend Favorite

RNAi in Plasmodium

Current Pharmaceutical Design, Vol. 20, Iss. 2, 2014-01 ,pp. : 278-283

Bentham Science Publishers

Access to resources Recommend Favorite

Medication Non-Adherence in the Elderly: How Big is the Problem?

By Carmel M. Hughes

Drugs & Aging, Vol. 21, Iss. 12, 2004-01 ,pp. : 793-811

Adis International

Access to resources Recommend Favorite

Rational Approaches Towards Lead Optimization of Kinase Inhibitors: The Issue of Specificity

Current Pharmaceutical Design, Vol. 19, Iss. 26, 2013-08 ,pp. : 4714-4738

Bentham Science Publishers

Access to resources Recommend Favorite